Premature ovarian insufficiency: symptoms and care

Premature ovarian insufficiency means the ovaries produce hormones and release eggs less consistently earlier than expected. Periods may become irregular or stop, and fertility can be affected. Activity can fluctuate, so occasional bleeding or ovulation may still occur. This differs from a predictable, permanent end to ovarian activity.

Common presentations include irregular periods or periods stopping, hot flushes, night sweats, vaginal dryness, sleep or mood changes, reduced sexual comfort and trouble getting pregnant. Symptoms vary because hormone production may change unevenly. Period changes deserve assessment even when other menopause-like symptoms are absent.

Sometimes no specific cause is found. Possible explanations include chromosome or genetic differences, autoimmune conditions, previous chemotherapy or radiotherapy, ovarian surgery and some infections or metabolic conditions. Conditions such as Turner syndrome can be associated with reduced ovarian function. Anovulation can also cause absent periods, but it is not the same diagnosis.

Ovarian activity can be intermittent, with periods returning after a gap. Hormone levels may change over time, and symptoms can come and go. Reduced oestrogen over a prolonged period can affect bone and cardiovascular health, so care often includes a longer-term plan rather than focusing only on bleeding patterns.

Risk may be higher with a family history, known chromosome or genetic condition, autoimmune disease, ovarian surgery, or cancer treatment involving chemotherapy or pelvic radiotherapy. Some people develop POI without any recognised risk factor. A risk factor is a reason for tailored review, not proof that ovarian insufficiency is present.

A clinician reviews menstrual history, symptoms, pregnancy possibility, medicines and health conditions. Blood tests may assess reproductive hormones and thyroid function, often with repeat testing because levels fluctuate. Further tests can explore autoimmune or genetic causes when appropriate. A bone density scan may be considered when reduced oestrogen or other risks could affect bone strength.

Care is individualised and may include hormone replacement therapy until around the usual age of menopause, unless it is unsuitable. This can ease flushes and protect bone and other tissues, but requires a review of medical history. Vaginal moisturisers, lubricants, counselling, and fertility support may address specific goals. A bone density scan can guide bone-health planning.

Keep a record of periods and symptoms, take prescribed treatment consistently and discuss contraception if pregnancy is not desired because intermittent ovulation can occur. Weight-bearing activity, adequate calcium and vitamin D intake, avoiding smoking and moderating alcohol can support bone health. Emotional support is appropriate when fertility or early hormone change feels difficult.

Lower ovarian hormone exposure can contribute to bone thinning, vaginal and urinary symptoms, and changes in cardiovascular risk. Fertility may be reduced, although ovarian activity is not always absent. Regular review helps adapt hormone treatment, bone care, sexual-health support and fertility planning to changing needs.

Many cases cannot be prevented, particularly when linked to genetic or autoimmune causes. When cancer treatment or ovarian surgery is planned, ask a specialist about fertility preservation and ways to reduce avoidable ovarian injury before treatment. Do not stop essential treatment without medical guidance.

A gynaecologist, reproductive endocrinologist or menopause specialist can confirm the diagnosis and coordinate hormone, bone and fertility care. A counsellor or fertility team may help with emotional and reproductive decisions. Bring cycle dates, symptoms, family history and treatment records to the consultation.